Symphogen
id:
symphogen-306-3471695
title:
Symphogen
text:
Symphogen is a biotechnology company located in Copenhagen, Denmark that develops protein drugs based on recombinant monoclonal antibody mixtures. These drugs are different from the polyclonal antibodies, as each antibody in the mixture is produced from one carefully selected clone. Their three main areas of therapeutic research are immunoglobulin replacement, cancer, and infectious diseases. The company was founded in 2000 and has patents on a drug discovery platform called Symplex and a drug m
brand slug:
wiki
category slug:
encyclopedia
description:
original url:
https://en.wikipedia.org/wiki/Symphogen
date created:
date modified:
2023-09-27T21:04:55Z
main entity:
{"identifier":"Q7661403","url":"https://www.wikidata.org/entity/Q7661403"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/9/94/Symphogen_Kirsten_Drejer_20110317_0230F_%288346276704%29.jpg","width":3030,"height":1957}
fields total:
13
integrity:
14